Who is sponsoring NCT04325854?

NCT04325854 is sponsored by Istituto Clinico Humanitas.

What drugs are being tested in NCT04325854?

Interventions in NCT04325854: I and II level ART procedure.

What condition does NCT04325854 study?

NCT04325854 studies Ectopic Pregnancy; Assisted Reproductive Technology.

Is NCT04325854 still recruiting?

NCT04325854 is currently completed. Last updated 30 March 2020.

Last reviewed 2020-03-30 · How we verify

NCT04325854

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk Factors for Ectopic Pregnancy: Comparison of Fresh and Warmed Transfers. Analysis of a 10 Years, a Single Center Experience.

Completed Last updated 30 March 2020

What this trial tests

trial testing I and II level ART procedure in Ectopic Pregnancy; Assisted Reproductive Technology in 27,377 participants. Completed in 31 December 2018.

Timeline

1 January 2009

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	Istituto Clinico Humanitas
Status	Completed
Study type	OBSERVATIONAL
Enrollment	27,377
Start date	1 January 2009
Primary completion	31 December 2018
Estimated completion	31 December 2018

Drugs / interventions tested

I and II level ART procedure

Conditions studied

Ectopic Pregnancy; Assisted Reproductive Technology — all drugs for Ectopic Pregnancy; Assisted Reproductive Technology →

Sponsor

Istituto Clinico Humanitas

Who can join

Eligibility, female only, with Ectopic Pregnancy; Assisted Reproductive Technology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ectopic pregnancy (EP) is a leading cause of maternal death during the first trimester of pregnancy. Previous studies have reported an increased incidence of EP in Assisted reproductive technologies techniques (ART) (Clayton et al., 2006), and in particular with fresh blastocyst embryo transfer compared with warmed embryo transfer (Londra et al., 2015). In consideration of the widespread use of ART techniques in gynaecology and the high morbidity and mortality associated with EP, providing further insight into the risk factors associated with EPs in ART appears of great relevance. The objective of this study is to compare the incidences of EPs in all ART procedures (both I and II level) in a single, third level ART center throughout a 10-year period. In addition, we also aim to revise recognized EP's risk factors among patients undergoing these procedure and to evaluate their impact in determining extrauterine implantation

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Ectopic pregnancy risk factors in infertile patients: a 10-year single center experience.
Cirillo F, Paladino I, Ronchetti C, Busnelli A, et al · · 2022 · cited 9× · PMID 36443354 · DOI 10.1038/s41598-022-24649-w

Verify or expand the search:

Other Istituto Clinico Humanitas trials

Trials by the same sponsor.

NCT06944288 — Microbiota as Early Diagnostic and predictivE Factor for Osteoarthritic Degeneration and Microbial Contamination · NA · not yet recruiting
NCT07358247 — Postoperative Outcomes of Single-stapled Anastomosis Combined With Transanal Natural Orifice Specimen Extraction · not yet recruiting
NCT07362342 — RIght VEntricle Response to Major Lung Resection in VATS and Robotic Surgery · not yet recruiting
NCT07346274 — Intra-operative Hypotension and Post-operative Lactate Level After Pancreatic-duodenectomy. · enrolling by invitation
NCT07491419 — The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04325854 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istituto Clinico Humanitas
Last refreshed: 30 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04325854.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing